baber/WOPTO huggingface dataset:
Patent PT-2002385-E (PT)
Title: Method of reading at least one bar code and system for reading a bar code
Inventor: GOUELIBO DIDIER
IPC: G06V30/224
Filed: 2007-04-02
Abstract: A method of reading at least one bar code carried by a substrate, the method including: a) generating, especially in an automatic manner, when presenting the bar code to a system for reading the bar code, at least one authentication cue related to an intrinsic physical characteristic of the substrate and independent of the data contained in the bar code, and b) allowing the reading of the bar code, only in the event of a positive authentication of the substrate or reading the bar code regardless of the result of the authentication of the substrate and in the event of negative authentication of the substrate, preventing access to just one part of the data contained in the bar code and/or to any data that may be associated with the bar code, and which is stored on a separate data medium from the substrate.
Patent PT-1976525-E (PT)
Title: Piperidine and piperazine derivatives
Inventor: LI XIAOYUAN
IPC: A61P25/00
Filed: 2007-01-22
Abstract: Compounds of general formula (Ia): in which R 1 , A 1 , m, X, n, Y and R 3  have any of the meanings given in the specification, have affinity for sigma receptors and are useful in the treatment of disorders of the central nervous system.
Patent PT-2089031-E (PT)
Title: Reduction of overweight or obesity
Inventor: EGRI JANOS
IPC: A61K31/4545
Filed: 2007-07-23
Abstract: O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime (BGP-15) or a pharmaceutically suitable acid addition salt thereof can be used for the prevention or reduction of weight gain or the reduction of the rate of body weight gain.
Patent PT-2076532-E (PT)
Title: Cytokine derivatives
Inventor: HARTLEY OLIVER
IPC: C07K14/52
Filed: 2007-07-25
Abstract: The invention relates to polypeptides comprising an N-terminal portion and a C-terminal portion, wherein said N-terminal portion comprises the signature sequence QGP[P or L] and the amino acid sequence of said C-terminal portion is at least 70% identical to SEQ ID NO: 1, and uses thereof.
Patent PT-2255142-E (PT)
Title: A method for firing ceramic products and a kiln therefor
Inventor: PRATELLA GIANLUCA
IPC: F27B9/12
Filed: 2009-03-25
Abstract: A method for firing products (100) in a ceramic kiln (1 ), the kiln (1 ) comprising at least a flame burner (4), which is at least provided with a supply conduit (46, 6) of the comburent, an outflow conduit (43, 8) of the hot gases from the kiln, and a heat exchanger (40, 42) in order to operate a heat exchange between the fluid which flow through the supply conduit (46, 6) and the outflow conduit (43, 8). The method comprises cooling the products (100) by means of injection of a cooling fluid into the kiln, via the outflow conduit (43, 8) of the at least a burner (4), when the burner (4) is unignited.
Patent PT-589840-E (PT)
Inventor: NORMAN HARDMAN DR
IPC: C07K16/42
Filed: 1993-09-15
Abstract: The invention relates to reshaped human monoclonal antibodies directed against isotypic determinants of immunoglobulin E (IgE), direct equivalents and derivatives of said antibodies. The molecules of the invention are useful for diagnostics, prophylaxis and treatment of allergy.
Patent PT-617019-E (PT)
Inventor: ROLF GROSSER DR
IPC: C07D213/55
Filed: 1994-03-11
Abstract: Enantiomerically pure 3R,5S-(+)-sodium erythro-(E)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-methoxymethylpyrid -3-yl]-3,5-dihydroxy-hept-6-enoate is prepared by first cyclising a corresponding racemic ester to give the racemic lactones and subsequently separating these chromatographically by means of a chiral stationary phase. Cleavage of the enantiomerically pure lactones by means of base gives the enantiomerically pure end products.
Patent PT-646379-E (PT)
Inventor: HOFFMANN JAMES ARTHUR
IPC: A61K38/28
Filed: 1994-08-09
Abstract: The present invention is directed to an insulin formulation comprising a suspension of Ultralente crystals and a total formulation zinc concentration of between about 0.5 milligrams to about 20 milligrams per 100 units of insulin. Greater than fifty percent of the total zinc in the formulation resides in the soluble fraction, rather than in complex with the insulin. This insulin formulation generally has a pH from between about 6.0 to about 7.4. In addition, the insulin formulation of the present invention does not contain other proteins like protamine. This zinc-modified formulation displays characteristics of a very long lasting human insulin product.
Patent PT-715638-E (PT)
Inventor: MIDHA SANJEEV
IPC: C08L51/00
Filed: 1994-08-09
Abstract: The present invention relates to water or alcohol soluble or dispersible silicone grafted thermoplastic elastomeric copolymers and to cosmetic and pharmaceutical compositions containing these copolymers. This invention especially relates to copolymers useful for hair styling purposes, and to hair styling compositions containing these copolymers. This invention further relates to copolymers useful for providing cosmetic and pharmaceutical compositions for topical application to the skin. These topical skin care compositions are useful for delivering and/or transdermally transporting active ingredients to or through the skin.
Patent PT-755438-E (PT)
Inventor: CURLESS CRAIG ERIC
IPC: C07K14/50
Filed: 1995-04-27
Abstract: The invention relates to the use of a phosphate glass as a phosphorous source in the media of high cell density bacterial fermentation processes in order to reduce metallophosphate precipitation reactions. The methods of the invention demonstrate a practical method for controlling levels of metallophosphate precipitation in both the nutrient media and the fermentor which also result in increased cell densities and are useful in a variety of high cell density bacterial fermentation processes.
Patent PT-808367-E (PT)
Title: Mucosal vascular addressins and uses thereof
Inventor: RINGLER DOUGLAS J
IPC: C12N1/19
Filed: 1996-02-12
Abstract: The present invention relates to isolated and/or recombinant nucleic acids which encode primate MAdCAMs, and to proteins or polypeptides referred to herein as isolated and/or recombinant primate MAdCAMs. The invention further relates to recombinant nucleic acid constructs, comprising a nucleic acid which encodes a primate MAdCAM of the present invention, a portion thereof, or a variant; to host cells comprising such constructs, useful for the production of recombinant proteins; the use of nucleic acids and/or proteins in assays to identify inhibitors (e.g., antagonists) of primate MAdCAM function; and to antibodies reactive with primate MAdCAM, which are useful in in vitro methods, diagnostic and/or therapeutic applications. The invention also relates to the treatment of individuals, particularly humans, suffering from a disease (e.g., inflammatory bowel disease) associated with leukocyte recruitment to the gastrointestinal tract or other tissues, for example, as a result of binding of leukocytes to cells expressing the molecule MAdCAM (gut-associated endothelium), comprising administering to the individual an effective amount of an agent, such as an antibody which inhibits the binding of leukocytes to MAdCAM.
Patent PT-846114-E (PT)
Inventor: LIN NAN-HORNG
IPC: A61P25/00
Filed: 1996-05-28
Abstract: Novel 3-pyridyloxymethyl heterocyclic ether compounds having formula (I), wherein * is a chiral center and n, X, R<1>, R<2>, A andB are specifically defined, which are useful in controlling chemical synaptic transmission; therapeutically-effective pharmaceutical compositions therof; and use of said compositions to selectively control synaptic transmission in mammals.
Patent PT-833692-E (PT)
Inventor: EVRARD RENAUD
IPC: B02C2/04
Filed: 1996-06-11
Abstract: PCT No. PCT/FR96/00879 Sec. 371 Date Apr. 6, 1998 Sec. 102(e) Date Apr. 6, 1998 PCT Filed Jun. 11, 1996 PCT Pub. No. WO96/41680 PCT Pub. Date Dec. 27, 1996A vibrating cone crusher which crushes material between a cone and a frustoconical ring located therearound. An annular frame supports the ring and a device for generating circular vibrations in a horizontal plane. Tie rods connect the frame to a cone holder. Vertical vibration that disrupts crusher operation is reduced or neutralized by positioning the center of gravity of the cone, the cone holder, the frame, and items supported thereon adjacent the plane of vibratory forces.
Patent PT-844159-E (PT)
Inventor: NAST JEAN-DANIEL
IPC: B61F5/22
Filed: 1997-11-17
Abstract: The system has levers (2) and a tilting cross-member (3) which is suspended from the bogie chassis (4) by the levers and has secondary suspension elements (5) between the tilting cross-member and the carriage body. The levers, cross-member and the bogie chassis form a trapezium of rigid articulated members in the radial plane, the smaller base of which is fixed to the cross-member and the larger base to the chassis, while the sides are formed by the levers. The bogie chassis has intermediate cross-members (9) which form, together with the levers and the tilting cross-member, an assembly which creates a predetermined angular rigidity between the bogie chassis and the carriage body.
Patent PT-948544-E (PT)
Inventor: KING DAVID JOHN
IPC: A61P19/02
Filed: 1997-12-10
Abstract: Monovalent antibody fragments are described, each of which has one or more polymer molecules site - specifically attached through a sulphur atom of a cysteine residue located outside of the variable region domain of the antibody. The polymers include synthetic or naturally occurring polymers such as polyalkylene, polyalkenylenes, polyoxyalkylenes or polysaccharides. Each fragment may be attached to one or more effector or reporter molecules, and is of use in therapy or diagnostics where it has markedly improved binding and/or pharmacokinetic properties when compared to other antibody fragments which have the same number and type of polymer molecules, but in which the polymer molecules are randomly attached.
Patent PT-909933-E (PT)
Inventor: GRAAFF ABRAHAM ANTHONY JOHN DE
IPC: F28F27/02
Filed: 1998-10-12
Abstract: A cross-flow heat exchanger (1) comprises two through-flow circuits physically separated from and thermally coupled to each other, which circuits are arranged in interwoven relation and through which flow, in mutual transverse direction, an air flow (14) from an outside air inlet (3) to a discharge (7) to the space for heating, and for instance an inlet (8) for hot flue gases (15) coming from the burner to a discharge (11) for flue gases (15) to the outside, which walls (13) are all substantially congruent and are held in mutual connection, which heat exchanger (1) has a substantially prismatic form. The heat exchanger (1) according to the invention has the feature that in the prismatic form a smaller prismatic part (18) serving as bypass circuit with the same section transversely of the main direction is free of walls and comprises a cavity (18) bounded by two walls (19,20), which cavity (18) forms part of the first through-flow circuit, in which cavity (18) is arranged a valve (21) which is displaceable between a closed position and an open position. <IMAGE>
Patent PT-975936-E (PT)
Inventor: SALMASI ZAREH SOGHOMONIAN
IPC: G01F1/58
Filed: 1998-04-24
Abstract: An electromagnetic flow meter and method of operating the same. There is provided a flow measurement duct, a magnetic circuit including pole pieces for generating a magnetic field in fluid flowing in a direction in the duct across the direction of flow, and an electrical circuit including at least one sensing electrode for measuring a voltage thereby induced in the fluid to provide an output indicative of the flow. The method comprises measuring a series of pairs of outputs of the electrical circuit, each pair of outputs comprising an output when the magnetic field is present and an output when the magnetic field is absent, and determining from the measured series of pairs of outputs whether fluid is present or absent in the duct.
Patent PT-1021791-E (PT)
Inventor: WEINLANDER MARKUS
IPC: G06F9/445
Filed: 1998-08-27
Abstract: A chip card has a program execution unit and a memory for at least one program that can be reloaded as a function of the application. In every reloadable program, first command instructions having absolute address parameters that refer to memory areas not occupied by the reloadable program are separated from second command instructions having absolute address parameters that refer to the memory area occupied by the reloadable program. It is possible for the reloadable program to be reloaded as a function of the application at any desired start address in the memory and to be adapted to that start address by the program execution unit. In particular, the need to create different reloadable program versions for possible application-related start addresses is dispensed with.
Patent PT-956975-E (PT)
Inventor: SOLMSDORF BERNHARD
IPC: B42D25/43
Filed: 1995-03-22
Abstract: A permit or access card has a laminated structure with a transparent cover (6) located over a metal layer (7) that is used to create an area providing protection against copying. The metal layer is formed over a layer (8) having specific optical characteristics and this is formed on an opaque layer (18). An identification pattern is formed in the metal layer with the aid of a laser. The layer beneath the metal layer has a specific optical characteristic corresponding to a part of the visible spectrum. The characteristics of the layer prevent the pattern alone or in combination with the metal layer from being exactly electrophotographically copied. The pattern may also be produced as a holographic image.
Patent PT-1006095-E (PT)
Title: Method for fabricating endodontic, orthodontic, and direct restorations having infused ceramic network
Inventor: GIORDANO RUSSEL ANTHONY II
IPC: A61K6/884
Filed: 1999-11-24
Abstract: The present invention provides a process for preparing a direct filling material and a paste-like direct filling material.
Patent PT-1144485-E (PT)
Inventor: YAMAMOTO TETSU
IPC: H01M8/10
Filed: 1999-12-11
Abstract: A method for producing a polyelectrolyte membrane, including the step of immersing a basic polymer such as a polybenzimidazole in a strong acid having a concentration sufficient to impregnate the basic polymer with six or more strong acid molecules per polymer repeating unit of the basic polymer at a temperature of not less than 30° C. for a period of 5 h or less, as well as a fuel battery having the polyelectrolyte membrane. Hence, the times required to immerse the basic polymers in the strong acids can be shortened and the proton conductivity of the polyelectrolyte membranes can be improved.
Patent SG-19691-G (SG)
Title: Liquid detergent compositions
IPC: C09K23/00
Filed: 1991-03-20
Abstract: Pourable, fluid, non sedimenting, laundry detergent composition, comprising water, surfactant, builder, a surfactant desolubilizing electrolyte and, optionally, the usual minor ingredients, consist essentially of : at least one predominantly aqueous liquid phase which is separable into a distinct layer by centrifuging the composition at 800 times normal earth gravity at 25 DEG  C. for 17 hours, and which contains at least part of the electrolyte and less than 75% by weight, preferably less than 10% by weight, of the surfactant, and one or more other phases which together contain at least part of the builder as solid particles dispersed in the composition and at least part of the surfactant, preferably either as a network of solid surfactant hydrate, or as a "G" phase liquid crystal which may be associated with an "L" phase, micellar solution.
Patent IE-35960-L (IE)
Title: Pharmaceutical preparation
IPC: C07D521/00
Filed: 1972-01-06
Abstract: 1369704 Pyrazole derivative SCIENCE UNION ET CIE SOC FRANCAISE DE RECHERCHE MEDICALE 11 Jan 1972 [15 Jan 1971] 1192/72 Heading C2C [Also in Division A5] 1-Benzoyl-3,5-dimethyl pyrazole having analgesic, anti-inflammatory, antirheumatic, U.V.- absorbing and lipolytic activity, is prepared by reacting 3,5-dimethylpyrazole with benzoyl chloride in the presence of triethylamine and ether. (From GB1369704 A) [FR2121461A1]
Patent IE-40352-L (IE)
Title: Thioxanthene -9- spiropiperidines
IPC: C07D495/10
Filed: 1975-01-07
Abstract: 1434486 Spiro piperidine/thiaxanthenes IMPERIAL CHEMICAL INDUSTRIES Ltd 2 Jan 1975 [4 Feb 1974] 05017/74 Heading C2C [Also in Division A5] The invention comprises compounds of formula and their pharmaceutically acceptable acid addition salts, wherein R<SP>1</SP> is H, C 1-10 alkyl, C 3-10 alkenyl, C 4-7 cycloalkyl-alkyl (optionally nuclear-substituted by C 6-10 aryl or by up to 2 C 1-3 alkyls), C 8-12 aroylalkyl (optionally nuclearsubstituted by 1-3 halogen atoms or C 1-3 alkyls) or C 2-5 hydroxyalkyl; R<SP>2</SP> ... R<SP>5</SP> are each H, halogen, OH or (up to C 5 ) alkyl, haloalkyl, alkoxy, alkylthio, alkanoyloxy or hydroxyalkyl; and A is S, SO or SO 2 . In examples, these compounds are prepared by (ii) reacting thiaxanthene with NaH/Me 2 SO and (2) reacting a 9,9-bis-(XCH 2 CH 2 )-thiaxanthene (or the S-oxide or dioxide) (Q) where X is Cl or MeSO 3 , with R<SP>1</SP>NH 2; (3) hydrolysing and decarboxylating the N-carbophenoxy compound; (4) reacting an N-cyano compound with LiAlH 4 followed by NaOH (for R<SP>1</SP>=H); (5) reducing an N - cycloalkylcarbonyl compound, (6) converting one or more of R<SP>2</SP> ... R<SP>5</SP>=MeO to HO, and HO to AcO. Starting materials and intermediates otherwise prepared are analogues of (I) where R<SP>1</SP> is benzyl; analogues of (Q) where X is OCH : CH 2 or OH, and the corresponding 9,9-unsubstituted or 9-oxo-thiaxanthenes; and the acids 2- (o-ROC 6 H 4 S)-C 6 H 4 CO 2 H where R is Me or Et and the ring containing the CO 2 H group may be further substituted. Therapeutic compositions having analgesic and in some cases sedative activity comprise compounds of the above formula. They may be administered orally, parenterally or rectally, and may contain further active ingredients (see Division A5).
[GB1434486A]
Patent IE-840069-L (IE)
Title: Control of swine dysentry
IPC: A23K1/18
Filed: 1984-01-13
Abstract: The antibiotic, avilamycin, is useful in the treatment or prevention of swine dysentery.
[US4436734A]
Patent IE-35998-L (IE)
Title: Sewage treatment
IPC: C02F1/52
Filed: 1972-01-20
Abstract: 1382161 Purifying sewage NORM AMC AG 20 Jan 1972 [21 Jan 1971] 2743/72 Heading C1C In a process for purifying sewage, e.g. removing phosphates, the sewage together with a flocculating or precipitating agent from conduit 13, is passed through conduit 10 to mixing zone 5 of tank 1 containing gyroscopic mixer 11 and the mixture is passed downwardly through flocculation zone 6 by helical screw 14, to sedimentation zone 3 where the sludge settles out from the purified water which is discharged from clear water zone 8 over weir 15. Some sludge may be recycled from zone 3 to zone 5 through pipe 16 by the suction of mixer 11. Sludge may be periodically discharged from zone 3 under the control of photoelectric means. The tank 1 may be substantially cone- or pyramid-shaped.
[GB1382161A]
Patent IE-900138-L (IE)
Title: Process for the encapsulation of preformed substrates by¹graft copolymerization
IPC: C08J7/04
Filed: 1990-01-12
Abstract: A process for encapsulating a preformed polymeric substrate comprises peroxidizing and hydroperoxidizing the surface of said preformed substrate using ozone and then carrying out a crosslinked graft copolymerization of selected ethylenically unsaturated monomers both on and surrounding (encapsulating) said substrate. Such encapsulation of substrates provides protective coatings, ablative coatings and, particularly, soft skirts for hard contact lenses.
Patent IE-810179-L (IE)
Title: Analysing combustion effluent gas for combustible or¹combustion-supporting constituents
IPC: G01N25/30
Filed: 1981-01-30
Abstract: A stream of internal combustion engine effluent gas is analysed for combustible or combustion-supporting constituents by separately in time passing an untreated sample of the gas and a sample treated by addition of whichever of a combustible and a combustion-supporting constituent it is deficient in through a reaction zone maintained in conditions effective to cause mutual reaction of combustible and combustion-supporting constituents and containing a temperature sensor, and measuring the difference in temperature between untreated and treated samples as the result of subjection to those conditions. <??>According to the drawing a stream of exhaust gas is equilibrated in zone 15 and divided into two streams, one of which receives an addition of gasoline vapour in chamber 22B, while the other passes through chamber 22A without addition. Then the streams from chambers 22A and 22B are passed alternatingly over hot wire 30 by the action of valve 27 actuated by external electromagnet 29. 
[EP0034013A2]
Patent IE-36126-L (IE)
Title: Diphenylamine derivatives
IPC: A01N37/44
Filed: 1972-02-29
Abstract: Title cpds. of formula (where Z = halogenated naphthyl or 2-X2-3-X1-4-Y-5-X3-6-X4-phenyl where Y = -NO2, CF3, halo or alkyl and X1, X2, X3, X4 = halo) are prepd. by reaction of a 2-amino-5-nitro-alpha, alpha, alpha-trifluorotoluene with a halogenated naphthalene or benzene deriv. in the presence of a base or by reaction of a halogenated naphthylamine or phenylamine deriv. with a 2-halo-5-nitro-alpha, alpha, alpha-trifluorotoluene. The cpds. are esp. useful as insecticides, algicides and for the control of bacterial and crytogamic plant diseases.
[FR2129775A5]
Patent IE-900559-L (IE)
Title: Delivery device for orally administered therapeutic agents
IPC: A47G21/18
Filed: 1990-02-15
Abstract: An improved device for containing and administering orally active therapeutic agents is described. A unit dose of a therapeutic agent in free-flowing form is retained and positioned for oral administration in a tube adapted to deliver the dose with a flow of liquid drawn through the tube by normal sipping action of a patient. The combination of small particle size and high flow rates into the alimentary canal allow dosage administration with minimal sensed contact with the oral cavity. The invention is particularly advantageous for the administration of orally active therapeutic agents to pediatric and geriatric patients.
Patent IE-42551-L (IE)
Title: Pre-coated microscope slides
IPC: G01N1/30
Filed: 1976-04-09
Abstract: Pre-coated microscope slides are produced on a large scale by spraying a dyestuff solution on to microscope slides which are passed at a constant speed under a spray nozzle, the pattern of which is kept rectangular by means of a mask.
[US4103041A]
Patent IE-900871-L (IE)
Title: Frequency control apparatus for a digital radio receiver
IPC: H04B7/26
Filed: 1990-03-12
Abstract: A frequency control apparatus for a burst-mode radio communications system (TDMA) employing a frequency correction signal transmitted as a burst to enable correction of frequency differences between the frequency of the radio carrier of a subsequent communication burst and the frequency of reception by a radio receiver, the frequency control apparatus including a variable frequency oscillator (115), for receiving a frequency correction signal burst and a digital signal processor (111) for processing a communication burst having a frequency difference between said variable frequency oscillator and the radio carrier frequency of said communication burst and for generating a singular control signal value and for applying said singular control signal value to said variable frequency oscillator (115), via an A/D converter, to correct said frequency difference.
[EP0389974A1]